Medtronic PLC (MDT)
Return on total capital
| Apr 30, 2025 | Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | — | 5,556,000 | 5,528,000 | 5,778,000 | 5,974,000 |
| Long-term debt | US$ in thousands | — | — | — | — | 21,700,000 |
| Total stockholders’ equity | US$ in thousands | 48,024,000 | 50,214,000 | 50,214,000 | 51,483,000 | 51,483,000 |
| Return on total capital | 0.00% | 11.06% | 11.01% | 11.22% | 8.16% |
April 30, 2025 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $48,024,000K)
= 0.00%
The return on total capital for Medtronic PLC has demonstrated some fluctuation over the period analyzed. Starting at 8.16% on April 28, 2023, the return improved to 11.22% on April 30, 2023, indicating a positive trend. However, there was a slight decline to 11.01% on April 26, 2024, and a marginal increase to 11.06% on April 30, 2024. The most recent data point, April 30, 2025, shows a return of 0.00%, suggesting a significant decrease or potentially an anomalous calculation.
Overall, while the return on total capital has generally been positive and relatively stable within the range of 8% to 11%, the sudden drop to 0.00% in the latest period may warrant further investigation to understand the underlying factors impacting Medtronic PLC's capital efficiency. Further analysis of the company's financial performance and strategies may be necessary to uncover the reasons behind this notable deviation in the return on total capital.
Peer comparison
Apr 30, 2025